Shares in Haemonetics (NYSE:HAE) rose today after the medical device maker beat expectations on Wall Street with its first quarter fiscal year 2019 earnings results. The Braintree, Mass.-based company posted losses of $2.8 million, or 5¢ per share, on sales of $229.4 million for the three months ended June 30, seeing a swing to red ink […]
Haemonetics
Dr. Gawande tapped to lead Amazon-JPM-Berkshire health play | Personnel Moves – June 21, 2018
The joint healthcare venture between Amazon (NSDQ:AMZN), Berkshire Hathaway and J.P. Morgan Chase said this week it named Brigham and Women’s Hospital surgeon, New Yorker magazine staff writer and bestselling author Dr. Atul Gawande as its CEO, effective July 9. The joint venture said that the newly formed company will be headquartered in Boston, and will operate […]
Haemonetics closes $700m debt refi
Haemonetics (NYSE:HAE) said today that it closed the refinancing of some $700 million in debt as part of its restructuring plan. Last November the Braintree, Mass.-based blood management company unveiled plans to cut roughly 11% of its global workforce as it looked to pare $80 million from its annual cash burn by the end of fiscal 2020. […]
Haemonetics swings to black for fiscal Q4, 2018
Haemonetics (NYSE:HAE) eked out a sales-and-earnings beat with its fiscal fourth-quarter and 2018 numbers today, posting swings to black ink for both periods. The Braintree, Mass.-based blood management company reported profits of $11.9 million, or 22¢ per share, on sales of $233.6 million for the three months ended March 31, compared with losses of -$51.1 million […]
Haemonetics shares rise on Q3 beat
Shares in Haemonetics (NYSE:HAE) rose today after the medical device maker beat expectations on Wall Street with its third quarter results. The Braintree, Mass.-based company posted losses of $6.5 million, or 12¢ per share, on sales of $234 million for the 3 months ended December 30, seeing the bottom line shrink 142.5% while sales grew 2.7% […]
Haemonetics to cut 11% of workforce
Haemonetics (NYSE:HAE) said today that it plans to cut roughly 11% of its global workforce as it looks to pare $80 million from its annual cash burn by the end of fiscal 2020. The Braintree, Mass.-based blood management company said it plans to eliminate 350 positions by the end of its fiscal year in April. The company reported […]
RTI Surgical taps director for CFO, fills out roster | Personnel Moves, Sept. 19, 2017
RTI Surgical (NSDQ:RTIX) said yesterday that it’s tapping a board member to be CFO and adding a pair of medical device veterans to its executive roster. Alachua, Fla.-based RTI said it named director Jonathon Singer as its finance & administration chief effective Oct. 2, replacing Robert Jordheim. Singer, who resigned his board seat to accept […]
Haemonetics wins FDA 510(k) for NexSys PCS plasmapheresis system
Haemonetics (NYSE:HAE) said today it won FDA 510(k) clearance for its NexSys PCS plasmapheresis system designed for collecting blood plasma. The NexSys PCS includes bi-directional connectivity to the Braintree, Mass.-based company’s NexLynk DMS donor management system, and allows for automated collection procedure programming and automated end of procedure documentation. “NexSys PCS is designed to increase productivity […]
Shockwave Medical picks up ex-HeartWare CEO Godshall | Personnel Moves – May 11, 2017
Shockwave Medical said today it tapped former HeartWare CEO Doug Godshall as its new prez & CEO. Godshall served as CEO of HeartWare for 10 years until the business was acquired by Medtronic (NYSE:MDT) for $1.1 billion last August, Fremont, Calif.-based Shockwave Medical said. Prior to his time at HeartWare, Godshall held various executive and leadership […]
Haemonetics shares steady on Q4, FY2017 earnings Beat
Shares in Haemonetics (NYSE:HAE) have stayed steady today, down only slightly after the medical device maker beat expectations on Wall Street with its 4th quarter and full 2017 fiscal year earnings results. The Braintree, Mass.-based company posted losses of $51.1 million, or 98¢ per share, on sales of $228.1 million for the 3 months ended April […]
Haemonetics posts Q3 beat, lifts guidance
Haemonetics (NYSE:HAE) today released its 3rd quarter earnings, topping expectations from analysts on The Street and raising its outlook for the rest of its fiscal year 2017. The Braintree, Mass.-based company posted profits of $15.4 million, or 30¢ per share, on sales of $227.8 million for the 3 months ended Dec. 31, for a significant swing […]